Dimethyl fumarate: targeting glycolysis to treat MS

A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis

(2018) Jürgen Brück et al.   EXPERIMENTAL DERMATOLOGY

Dimethyl fumarate influences innate and adaptive immunity in multiple sclerosis

(2018) Martin Diebold et al.   JOURNAL OF AUTOIMMUNITY

Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity

(2018) Michael D. Kornberg et al.   SCIENCE

Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple Sclerosis

(2018) Elizabeth A. Mills et al.   Frontiers in Neurology

Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1

(2018) Evanna L. Mills et al.   NATURE

Targeting Metabolism as a Novel Therapeutic Approach to Autoimmunity, Inflammation, and Transplantation

(2017) Ian A. Bettencourt et al.   JOURNAL OF IMMUNOLOGY

Identification of protein succination as a novel modification of tubulin

(2014) Gerardo G. Piroli et al.   BIOCHEMICAL JOURNAL

The succinated proteome

(2013) Eric D. Merkley et al.   MASS SPECTROMETRY REVIEWS